The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Yes, it is clearly a binary play.
And if a deal/deals are reached, then why the need for a raise?
We need to secure upfront and staged payments as part of any deal IMO, or it is going to be a hard sell to shareholders.
The part where Iain mentions the need for shareholder support is why the SP has not rocketed on the last update, which I agree is tentatively positive.
Happy to have expectations managed of course, but either we have something of commercial value or we do not.
And the time is fast approaching where we will know the answer to this question. GLA.
Allenby Capital Research Note released post-presentation. Their valuation of Reneuron for one exosome deal is now 55p per share.
https://www.allenbycapital.com/client/reneuron-plc/
There have been some decent deals for Exosomes, so there must be a concensus that exosomes are a worthy pursuit.
If exosomes are the carrier and drug delivery mule of the future, Reneuron's CustomEX platform will be worth at least the current MCap. 😄
Are they going to achieve a deal with some upfront cash is the question, and it's needed inside 3 months.
I think it's been said a few times, this is now a binary play. If there is a company out there that sees Rene's Exosomes as the best possible fit the reward could be worth waiting for.
I'm not holding a huge number of shares but I'm going to stay invested as there are some signs of possible green shoots.
Good luck to all.
Chester.
It is the previous BOD who must bare the most responsibility for providing such a dreadful result to shareholders.
All that said, I had hoped Iain would have secured at least one deal by now.
The time is now approaching where his own reputation and credibility is going to come under scrutiny I think.
He has been in post for long enough now to secure something that will encourage remaining shareholders to continue to support the operation IMO.
Such as a raise at a decent premium to the price today - with all BOD members participating heavily from their own pockets - or a sale, where we get something back, even if not made whole.
Which for any LTH's, will not be much comfort.
A bucket shop CLN deal for example, would simply tell me that this is probably just another AIM lifestyle outfit.
And I will then leave the stage for the pump and dump crews to then do what they do before the next raise - or suspension/lights out a few months, or however long, down the line from there.
But I have not given up on Iain yet, and I remain truly hopeful that he can pull a rabbit out of the hat. GLA.
I for one will not be putting any money in to Rene, because for 20 years I have stayed loyal putting thousands into there pot, I simply believed that they would come good when my daughter was born I really thought this company was going to make it big but my daughter is now in her late twenty, I stupidly thought one day she might have a little nest egg to help her in life. Rene has told lie after lie, it,s very sad.stemcells are the future AstraZeneca got it right reneuron got it wrong so very wrong. would you put money into this Co, I don,t think so.
Looks like they will be coming to the shareholders cap in had again very soon.
Here's the link to the presentation:
https://www.reneuron.com/wp-content/uploads/Cell-2023_November-2023.pdf
Very interesting RNS...would have probably pushed the SP up for a lot of shares but shows how unfashionable we are at the moment
Maybe there's one last twist in the tail after all. Certainly a very positive RNS, and it will be interesting to hear what comes from the conference today. Need a licencing deal signing to keep the lights on though. If they're discussing terms with partners then I presume no further director buys would be possible.
Basically, yes. Let's hope Iain can win over some hearts and minds (and financial backing) at the presentation today.
Some more inside buying would be welcome too and IMO will increase the prospect of 'shareholder support' as alluded to in said RNS.
Still a death or glory prospect. I continue to hold at this point in time, but we all know the risks here. GLA.
Everything else is noise
So what’s happened to Fosun?
Small buys, and nothing since, cash declining along with share price
Answer lower then a snakes boll cks and they don,t come much lower then that!
Clinging on to the hope from those director buys in the summer....odd thing for them to do if it's all doom and gloom but equally can't see any big numbers in terms of a buy out
Any further equity raise is completely unrealistic at this point. So they either are expecting/confident of signing licencing deals, or busy drafting the RNS that confirms the lights are being switched off and trying to find anyone who's willing to stump up for the IP. With an MCAP of £2.9m, you would hope/presume the IP is worth more than that, but only if someone actually wants it.
With no news of deals and therefore the audit's worst case scenario of cash runway to February 2024 looking ever more likely, should we assume that deals ARE in the offing?
Leaving only 3 months to fundraise via. issuing stock, with Christmas in the middle, doesn't seem prudent.
Rene is like a floating bath tub, the only trouble is somebody has thrown the plug away, just a matter of time before it sinks, all hands on deck pronto.
If there is nothing to say why say anything good news would be a first with this company you stand a better chance with premium bonds after 5 or 10 years you can get your money back, with Rene you got no chance!
They attended the conference but due to the commercially sensitive data, decided not to guest speak.
As the conference was not mentioned in an RNS, they did not deem it necessary to RNS this decision.
I did not receive any sensitive information...but I am satisfied to continue to hold at the time of print.
Not advice etc and GLA.
Nothing personal Sajy.
As a LT stock holder, I’ve watched the stock price consistently fall, I’ve also noticed that most posters were, what I would call optimists; less polite individuals may call it ramping.
Rarely has there been a dissenting voice on this board, such that any new reader may get a distorted view of prospects and may be unduly influenced as a result to buy.
I take no pleasure in my contra/balancing views having been in the main right as I too will lose my shirt! I appreciate it may be unwelcome and will leave it at that; particularly as we can’t get much lower. Your filter will therefore be unnecessary.
Surprised2 you have now been filtered as I do not have time for idiots. My post did say it was my gut feeling and that means my thoughts and not what the company have said. So get of your high horse and stop making accusations. It's idiots like you that prevent people posting, from now on I will keep my thoughts to myself.
Sajy, are you suggesting that Mr Ross and his board are hiding data that may affect the share price?
My limited understanding of UK law is that to raise funds, Rene must in return meet a number of transparency obligations: particularly making public significant information liable to impact the share price. But of course you may have an inside track to Mr Ross’ office.
Rene did attend the conference but decided against presenting the data. What could be the reason for this? Well we know that they have generated good data as stated in the recent Rns, so it's not because the data was not good. We also know that they are in discussions with third parties to sign deals. My gut feeling is that Rene have been asked not to reveal the latest data while discussions are ongoing by the third parties. I believe once a deal or deals have been signed then we will get a more comprehensive update on the data.
👍